Tag Archive for Earnings Report

Natura Completes Corporate Streamlining, Reports R$ 6.2 Billion Revenues in Q4 2025

SÃO PAULO, Brazil – Natura (B3: NATU3) today presented its fourth-quarter and full-year 2025 results. In a year marked by the final steps of its corporate streamlining process, the Company sharpened its focus on Latin America and achieved strong profitability growth. The recurring EBITDA margin in the region reached 16.1% in 4Q-25. For the full year 2025, recurring profitability was 14.6%, an increase of 130 basis points compared to the previous year.
Highlights

Divestments of Avon International and Avon Russia mark the conclusion of the corporate streamlining process
Completion of the Natura–Avon brand unification (Wave 2) in Mexico and Argentina brings transformation costs to a close, coming in below 2024 levels
Annual recurring EBITDA margin reaches 14.6% (+130 bps increase), driven by the 16.1% growth in 4Q-25 in Latin America
Solid cash generation, despite revenue challenges, leads to leverage within the optimal range by the end of 2025
Continuing operations delivering net income of nearly R$ 1 billion

The completion of the sales of Avon International and Avon Russia marked the final milestone in Natura’s corporate streamlining and capital structure reorganization. The Company ended the year with financial leverage at 1.31x, within the optimal capital structure range.
With the integration of Mexico and Argentina, the operational unification of

Read more...

Nature’s Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

LEHI, Utah – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.
Summary of Q4 and Full Year 2025 Results
Q4 2025 FINANCIAL SUMMARY VS. SAME YEAR-AGO QUARTER

Net sales increased 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).
GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.
Adjusted EBITDA up 16% to $11.9 million compared to $10.3 million.

FULL YEAR 2025 FINANCIAL SUMMARY VS. 2024

Net sales increased 5.7% to $480.1 million compared to $454.4 million (up 5.3% in constant currency).
GAAP net income attributable to common shareholders of $19.5 million, or $1.06 per diluted share, compared to $7.7 million, or $0.40 per diluted share.
Adjusted EBITDA up 21.7% to $49.4 million compared to $40.5 million.

Click to read the detailed report on Q4 and FY 2025 for Nature’s Sunshine
Management Commentary

“We finished a record year in sales and delivered our second‑best quarter ever and our largest Q4 on record, with sales and adjusted EBITDA up 5% and 16%, respectively,”

Read more...

Nu Skin Enterprises Reports Third Quarter Earnings

Company preparing for limited introduction of Prysm iO and pre-market opening of India in the fourth quarter
Nu Skin Enterprises Inc. (NYSE: NUS) announced third quarter revenue and earnings per share within its guidance range.
Ryan Napierski, Nu Skin president and CEO, stated:

“We are pleased with our third quarter results, which were in line with expectations, as we continue to navigate a challenging macro environment while preparing for the introduction of our intelligent wellness platform.

“Our Latin America region once again delivered strong, double-digit year-over-year growth, and we’re encouraged by positive trends such as sequential growth in several of our reporting segments. Through disciplined execution and operational efficiency, we delivered earnings per share at the high end of our guidance range.”

Napierski continued:

“As we look ahead, there is growing excitement and energy for the upcoming launch of our Prysm iO intelligent wellness platform and our expansion into India – two pivotal milestones that will accelerate our vision to become the world’s leading intelligent beauty and wellness company. Our leaders are eager to begin building with Prysm iO with a limited sales leader preview in late Q4 followed by broader sales leader availability and a full consumer launch in 2026. We believe our AI-powered wellness

Read more...

Zinzino Reports Record-Breaking Q2 Growth: Over 56% Increase in Group Revenue

Zinzino Solidifies Its Position As One of the World’s Fastest-Growing Wellness Companies.
Zinzino AB (publ), the publicly listed wellness company on Nasdaq First North, has released its preliminary Q2 2025 earnings report, showing extraordinary global expansion and accelerating momentum in its partner-driven business model.
📈 Group revenue rose 56% year-over-year, reaching SEK 791 million in Q2 alone.
📈 June 2025 sales surged 71% to SEK 255.8 million in the Zinzino sales markets.
📈 H1 2025 revenue hit SEK 1.51 billion, a 58% increase over the first half of 2024.
These results reflect Zinzino’s rising dominance in test-based wellness, rooted in personalized health, science-backed products, and a transparent partner compensation system.
🚀 Global Market Momentum

Zinzino’s strongest expansion in Q2 came from global growth markets:

Asia-Pacific: +538%
North America: +204%
Central Europe: +60%
South & West Europe: +53%
Africa: +50%

The company continues to operate debt-free, with no venture capital influence, and maintains over 80% of revenue from recurring customer product orders. Its stock, which traded around 25 SEK in 2022, has now crossed 257 SEK — a testament to strong investor confidence and long-term vision.
💬 CEO Statement

“These numbers are more than just percentages,”

says Dag Pettersen, CEO of Zinzino.

“They represent years of groundwork, the passion of our Partners, and our firm belief that

Read more...

Nu Skin Reports First Quarter Revenue at High End of Guidance

Nu Skin (NYSE: NUS) announced first quarter revenue at the high end of its guidance range.
Executive Summary: Q1 2025 vs. Prior-year Quarter

Revenue

$364.5 million; (12.7)%
(3.0)% FX impact or $(12.3) million

Earnings Per Share
(EPS)

$2.14 or $0.23 excluding Mavely gain and other charges compared to $(0.01) or $0.09 excluding restructuring charges

Customers

776,712; (11)%

Paid Affiliates

131,518; (15)%

Sales Leaders

31,036; (20)%

“We are pleased to achieve revenue at the high end of our guidance range and exceed our adjusted earnings forecast to start out the year,”

Ryan Napierski, Nu Skin president and CEO said.

“We drove year-over-year growth in Latin America and our Rhyz manufacturing segment, but we continue to experience consumer caution in premium beauty due to concerns such as inflation and tariffs in many parts of the world. Through 2025, we remain focused on building on our recent product launches and preparing for the preview of our Prysm iO intelligent wellness device in the back half of the year. This palm-sized device provides real-time insights into a customer’s health, informing recommendations for product subscriptions and increasing customer satisfaction and loyalty. We are also laying the groundwork for expansion into India with a market pre-opening in Q4 and formal launch in mid-2026 and prioritizing our efforts to continue improving margins across the board.”

Q1

Read more...